These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 1839385)

  • 1. Similar effects of treatment with desipramine and electroconvulsive shock on 5-hydroxytryptamine1A receptors in rat brain.
    Pandey SC; Isaac L; Davis JM; Pandey GN
    Eur J Pharmacol; 1991 Sep; 202(2):221-5. PubMed ID: 1839385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desipramine, administered chronically, influences 5-hydroxytryptamine1A-receptors, as measured by behavioral tests and receptor binding in rats.
    Lund A; Mjellem-Jolly N; Hole K
    Neuropharmacology; 1992 Jan; 31(1):25-32. PubMed ID: 1531864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation by electroconvulsive shock and antidepressant drugs of the 5-HT1A receptor-mediated hypothermia and serotonin syndrome produced by 8-OH-DPAT in the rat.
    Goodwin GM; De Souza RJ; Green AR
    Psychopharmacology (Berl); 1987; 91(4):500-5. PubMed ID: 2954178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The GTP-insensitive component of high-affinity [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding in the rat hippocampus corresponds to an oxidized state of the 5-hydroxytryptamine1A receptor.
    Emerit MB; Miquel MC; Gozlan H; Hamon M
    J Neurochem; 1991 May; 56(5):1705-16. PubMed ID: 1826520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroendocrine response to clonidine and 8-OH-DPAT in rats following chronic administration of desipramine or sertraline.
    O'Donnell JM; Grealy M
    Br J Pharmacol; 1992 Apr; 105(4):863-8. PubMed ID: 1387021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic, combined treatment with desipramine and mianserin: enhanced 5-HT1A receptor function and altered 5-HT1A/5-HT2 receptor interaction in rats.
    Lund A; Mjellem N
    Pharmacol Biochem Behav; 1993 Aug; 45(4):777-83. PubMed ID: 8415816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
    Hall MD; el Mestikawy S; Emerit MB; Pichat L; Hamon M; Gozlan H
    J Neurochem; 1985 Jun; 44(6):1685-96. PubMed ID: 3157780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of acute and repeated administration of T3 to mice on 5-HT1 and 5-HT2 function in the brain and its influence on the actions of repeated electroconvulsive shock.
    Heal DJ; Smith SL
    Neuropharmacology; 1988 Dec; 27(12):1239-48. PubMed ID: 2977427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single dose of 8-OH-DPAT reduces raphe binding of [3H]8-OH-DPAT and increases the effect of raphe stimulation on 5-HT metabolism.
    Beer M; Kennett GA; Curzon G
    Eur J Pharmacol; 1990 Mar; 178(2):179-87. PubMed ID: 1691712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR; Peroutka SJ
    Biochem Pharmacol; 1986 Jun; 35(12):1943-9. PubMed ID: 3013203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in serotonin 1A receptors in the dentate gyrus as revealed by autoradiographic analysis following repeated electroconvulsive shock but not imipramine treatment.
    Hayakawa H; Shimizu M; Nishida A; Motohashi N; Yamawaki S
    Neuropsychobiology; 1994; 30(2-3):53-6. PubMed ID: 7800163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.
    Hashimoto T; Nishino N; Nakai H; Tanaka C
    Life Sci; 1991; 48(4):355-63. PubMed ID: 1824956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential interactions of dimethyltryptamine (DMT) with 5-HT1A and 5-HT2 receptors.
    Deliganis AV; Pierce PA; Peroutka SJ
    Biochem Pharmacol; 1991 Jun; 41(11):1739-44. PubMed ID: 1828347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolving concepts on the interactions between antidepressant treatments and monoamine neurotransmitters.
    Green AR
    Neuropharmacology; 1987 Jul; 26(7B):815-22. PubMed ID: 2889156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of repeated electroconvulsive shock on serotonin1A receptor binding and receptor-mediated hypothermia in the rat.
    Stockmeier CA; Wingenfeld P; Gudelsky GA
    Neuropharmacology; 1992 Nov; 31(11):1089-94. PubMed ID: 1475018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.